Cobalt Therapeutics, LLC offers products that fit seamlessly into current clinical settings and enhance their therapeutic offerings to patients, decrease costs, and improve outcomes.
These programs have been evaluated in randomized, controlled trials
and published in leading peer-reviewed journals.
MoodCalmer™ is web-based and derived from an earlier program called COPE. In an open multi-site trial across two continents, COPE was shown to:
The program helps users develop long-lasting improvements in depression by teaching them new cognitive and behavioral skills.